Impaired control of L-type voltage-dependent calcium channels in experimental hypertension

M Pintérová1, S Líšková, Z Dobešová

  • 1Center for Cardiovascular Research, Prague, Czech Republic.

Physiological Research
|February 6, 2010
PubMed

Insights

Hypertension involves an imbalance between vasoconstrictors and vasodilators. This study investigates elevated calcium influx via L-type voltage-dependent calcium channels (L-VDCC) in hypertensive rats, even without sympathetic or nitric oxide influence.

Area of Science:

  • Cardiovascular Physiology
  • Renal Physiology
  • Pharmacology

Background:

  • Blood pressure regulation depends on the balance between vasoconstrictors (sympathetic nervous system) and vasodilators (nitric oxide).
  • Experimental hypertension often involves sympathetic hyperactivity and endothelial dysfunction.
  • Nitric oxide and norepinephrine antagonistically regulate calcium influx via L-type voltage-dependent calcium channels (L-VDCC).

Purpose of the Study:

  • To investigate the mechanisms underlying elevated calcium influx through L-VDCC in hypertensive rats.
  • To determine if cyclic nucleotides directly affect L-VDCC or modulate ion channels influencing membrane potential.
  • To elucidate the persistent elevation of blood pressure in spontaneously hypertensive rats despite interventions.

Main Methods:

  • Studies were conducted on rats with genetic or salt-induced hypertension.
  • Experiments involved assessing the roles of nitric oxide and sympathetic nervous system activity.
  • Calcium influx through L-VDCC was evaluated, along with the effects of nifedipine, ganglionic blockade, and NO synthase inhibition.

Main Results:

  • Hypertensive rats exhibit a relative nitric oxide deficiency and enhanced sympathetic vasoconstriction.
  • Elevated calcium influx through L-VDCC, sensitive to nifedipine, was observed in hypertensive rats.
  • Blood pressure remained elevated in spontaneously hypertensive rats even after ganglionic blockade and NO synthase inhibition, indicating an augmented nifedipine-sensitive component.

Conclusions:

  • A dysregulation in vasoconstrictor and vasodilator systems contributes to hypertension.
  • Augmented calcium influx through L-VDCC persists in hypertensive rats, independent of major vasoactive systems.
  • Further research is needed to understand the intrinsic mechanisms driving L-VDCC hyperactivity in hypertension.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...